rs775860642

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP3BP6BS2

The NM_000543.5(SMPD1):​c.107_112delTGCTGG​(p.Val36_Leu37del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00179 in 1,546,720 control chromosomes in the GnomAD database, including 16 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V36V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0014 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0018 ( 16 hom. )

Consequence

SMPD1
NM_000543.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 1.67

Publications

2 publications found
Variant links:
Genes affected
SMPD1 (HGNC:11120): (sphingomyelin phosphodiesterase 1) The protein encoded by this gene is a lysosomal acid sphingomyelinase that converts sphingomyelin to ceramide. The encoded protein also has phospholipase C activity. Defects in this gene are a cause of Niemann-Pick disease type A (NPA) and Niemann-Pick disease type B (NPB). Multiple transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2010]
SMPD1 Gene-Disease associations (from GenCC):
  • acid sphingomyelinase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Niemann-Pick disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Niemann-Pick disease type A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • Niemann-Pick disease type B
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_000543.5
BP6
Variant 11-6390700-CCTGGTG-C is Benign according to our data. Variant chr11-6390700-CCTGGTG-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 256590.
BS2
High Homozygotes in GnomAdExome4 at 16 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMPD1NM_000543.5 linkc.107_112delTGCTGG p.Val36_Leu37del disruptive_inframe_deletion Exon 1 of 6 ENST00000342245.9 NP_000534.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMPD1ENST00000342245.9 linkc.107_112delTGCTGG p.Val36_Leu37del disruptive_inframe_deletion Exon 1 of 6 1 NM_000543.5 ENSP00000340409.4

Frequencies

GnomAD3 genomes
AF:
0.00141
AC:
196
AN:
139132
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.000742
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00126
Gnomad ASJ
AF:
0.000892
Gnomad EAS
AF:
0.00312
Gnomad SAS
AF:
0.00369
Gnomad FIN
AF:
0.00168
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00156
Gnomad OTH
AF:
0.00211
GnomAD2 exomes
AF:
0.00264
AC:
613
AN:
232506
AF XY:
0.00269
show subpopulations
Gnomad AFR exome
AF:
0.00215
Gnomad AMR exome
AF:
0.00194
Gnomad ASJ exome
AF:
0.000309
Gnomad EAS exome
AF:
0.00332
Gnomad FIN exome
AF:
0.00292
Gnomad NFE exome
AF:
0.00271
Gnomad OTH exome
AF:
0.00193
GnomAD4 exome
AF:
0.00183
AC:
2572
AN:
1407484
Hom.:
16
AF XY:
0.00188
AC XY:
1318
AN XY:
700306
show subpopulations
African (AFR)
AF:
0.000695
AC:
23
AN:
33114
American (AMR)
AF:
0.00209
AC:
90
AN:
43044
Ashkenazi Jewish (ASJ)
AF:
0.000158
AC:
4
AN:
25306
East Asian (EAS)
AF:
0.00220
AC:
79
AN:
35856
South Asian (SAS)
AF:
0.00371
AC:
306
AN:
82498
European-Finnish (FIN)
AF:
0.00297
AC:
148
AN:
49770
Middle Eastern (MID)
AF:
0.00214
AC:
12
AN:
5608
European-Non Finnish (NFE)
AF:
0.00166
AC:
1782
AN:
1074246
Other (OTH)
AF:
0.00221
AC:
128
AN:
58042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
158
316
475
633
791
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00141
AC:
196
AN:
139236
Hom.:
0
Cov.:
0
AF XY:
0.00165
AC XY:
112
AN XY:
67720
show subpopulations
African (AFR)
AF:
0.000739
AC:
28
AN:
37864
American (AMR)
AF:
0.00126
AC:
18
AN:
14326
Ashkenazi Jewish (ASJ)
AF:
0.000892
AC:
3
AN:
3362
East Asian (EAS)
AF:
0.00312
AC:
15
AN:
4804
South Asian (SAS)
AF:
0.00369
AC:
15
AN:
4062
European-Finnish (FIN)
AF:
0.00168
AC:
15
AN:
8952
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
256
European-Non Finnish (NFE)
AF:
0.00156
AC:
98
AN:
62990
Other (OTH)
AF:
0.00208
AC:
4
AN:
1920
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
12
24
35
47
59
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00178
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SMPD1: PM4, BS2

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Sphingomyelin/cholesterol lipidosis Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Mar 08, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SMPD1 c.107_112delTGCTGG (p.Val36_Leu37del) results in an in-frame deletion that is predicted to remove two amino acids from the encoded protein. The variant allele was found at a frequency of 0.0026 in 232506 control chromosomes, predominantly at a frequency of 0.0038 within the South Asian subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 1.7 fold of the estimated maximal expected allele frequency for a pathogenic variant in SMPD1 causing Niemann-Pick Disease phenotype (0.0022), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Two classified as benign/likely benign while one classified as VUS. Based on the evidence outlined above, the variant was classified as benign.

SMPD1-related disorder Benign:1
Mar 15, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Niemann-Pick disease, type A Benign:1
Aug 10, 2017
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.7
Mutation Taster
=199/1
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs775860642; hg19: chr11-6411930; COSMIC: COSV54969884; COSMIC: COSV54969884; API